Physician profile
Robert W Oconnor
NPI 1265589774
$4,372.62
in general payments reported to CMS, 2019-2025
10 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $101 · 2021: $325 · 2022: $1,349 · 2023: $1,865 · 2024: $172 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,180 · Travel and Lodging: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,180.15 |
| Travel and Lodging | $1,155.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,747.31 | 2019-2025 | T2 Alpha, Axsos, Restoration |
| Arthrex, INC. | $717.16 | 2023 | |
| Skeletal Dynamics INC | $687.06 | 2023 | Align, Implate, Ijs |
| Cgg Medical INC | $591.45 | 2022-2025 | |
| Smith+Nephew, INC. | $219.45 | 2019-2025 | Trigen Intertan |
| Depuy Synthes Sales INC. | $193.01 | 2022-2024 | Na |
| Microport Orthopedics INC | $148.79 | 2021 | |
| Medartis INC. | $29.91 | 2019 | |
| Pacira Therapeutics, INC. | $19.34 | 2019 | |
| Boston Scientific Corporation | $19.14 | 2023 | Wavewriter Alpha Prime 16 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Oconnor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.